• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Leishen Energy Holding Co., Ltd. - Ordinary Shares (NQ:LSE)

4.450 +0.180 (+4.22%)
Streaming Delayed Price Updated: 1:06 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,494
Open 4.297
Bid (Size) 4.380 (100)
Ask (Size) 4.440 (800)
Prev. Close 4.270
Today's Range 4.297 - 4.450
52wk Range 4.030 - 14.99
Shares Outstanding 15,500,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma
January 04, 2026
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
December 30, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire

Performance

YTD
+4.2%
+4.2%
1 Month
-15.1%
-15.1%
3 Month
-15.2%
-15.2%
6 Month
-18.6%
-18.6%
1 Year
-18.9%
-18.9%

More News

Read More
News headline image
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma
December 29, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Director/PDMR Shareholding Notification
December 23, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Zimbabwe government amends proposed changes to the royalty and tax regimes
December 19, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers
December 17, 2025
From AVACTA GROUP PLC
Via GlobeNewswire
News headline image
HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors
December 16, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Utilisation of the block admission in respect of ATM Sales Agreement
December 16, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholder
December 10, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+ in patients with first line advanced melanoma
December 09, 2025
From Scancell Holdings Plc
Via GlobeNewswire
News headline image
HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China
December 07, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Empire to Present at the Precious Metals & Critical Minerals Virtual Investor Conference
December 01, 2025
From Virtual Investor Conferences; Empire Metals Limited
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Proposed Changes to Royalty and Tax Regimes in Zimbabwe
December 01, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Reminder of Remote Presentation on Publication of Feasibility Study for Bilboes Gold Project in Zimbabwe
November 28, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
November 26, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Publication and Highlights of the Feasibility Study for Bilboes Gold Project
November 25, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
UPDATE - Leishen Energy(LSE) Makes a Strong Debut at ADIPEC Abu Dhabi, Embarking on a New Chapter of Strategic Expansion in the Middle East and International Markets
November 13, 2025
From Leishen Energy Holding Co., Ltd.
Via GlobeNewswire
News headline image
Caledonia approves quarterly dividend
November 10, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc: Abridged Quarterly Results and Details of Management Conference Call for the three and nine months ended September 30, 2025 (“Q3 2025” or “the Quarter”)
November 10, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
Leishen Energy(LSE) Makes a Strong Debut at ADIPEC Abu Dhabi, Embarking on a New Chapter of Strategic Expansion in the Middle East and International Markets
November 09, 2025
From Leishen Energy Holding Co., Ltd.
Via GlobeNewswire
News headline image
Research Update
November 07, 2025
From Scancell Holdings Plc
Via GlobeNewswire
News headline image
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
November 05, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Caledonia Mining Corporation Plc Appointment of July Ndlovu as Independent Non-Executive Director
November 05, 2025
From Caledonia Mining Corporation Plc
Via GlobeNewswire
News headline image
HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO® Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO®
November 04, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
News headline image
HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event
November 02, 2025
From HUTCHMED (China) Limited
Via GlobeNewswire

Frequently Asked Questions

Is Leishen Energy Holding Co., Ltd. - Ordinary Shares publicly traded?
Yes, Leishen Energy Holding Co., Ltd. - Ordinary Shares is publicly traded.
What exchange does Leishen Energy Holding Co., Ltd. - Ordinary Shares trade on?
Leishen Energy Holding Co., Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Leishen Energy Holding Co., Ltd. - Ordinary Shares?
The ticker symbol for Leishen Energy Holding Co., Ltd. - Ordinary Shares is LSE on the Nasdaq Stock Market
What is the current price of Leishen Energy Holding Co., Ltd. - Ordinary Shares?
The current price of Leishen Energy Holding Co., Ltd. - Ordinary Shares is 4.450
When was Leishen Energy Holding Co., Ltd. - Ordinary Shares last traded?
The last trade of Leishen Energy Holding Co., Ltd. - Ordinary Shares was at 01/05/26 01:06 PM ET
What is the market capitalization of Leishen Energy Holding Co., Ltd. - Ordinary Shares?
The market capitalization of Leishen Energy Holding Co., Ltd. - Ordinary Shares is 68.97M
How many shares of Leishen Energy Holding Co., Ltd. - Ordinary Shares are outstanding?
Leishen Energy Holding Co., Ltd. - Ordinary Shares has 69M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap